We are pleased to report that Baumarine by Maruklav ended March 2022 at +$3 226/day better than our P5TC benchmark, closing Q1 qt +$100/day above benchmark, with April’s 2022 forecast showing +$2 376/day better than benchmark. Graf comments, “while securing strong Q1 earnings, we have continued to build for successful results in Q2 and the .